array:24 [
"pii" => "S0300289623001886"
"issn" => "03002896"
"doi" => "10.1016/j.arbres.2023.06.007"
"estado" => "S300"
"fechaPublicacion" => "2023-09-01"
"aid" => "3341"
"copyright" => "SEPAR"
"copyrightAnyo" => "2023"
"documento" => "article"
"crossmark" => 1
"subdocumento" => "fla"
"cita" => "Arch Bronconeumol. 2023;59:566-74"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:1 [
"total" => 0
]
"itemSiguiente" => array:18 [
"pii" => "S0300289623002090"
"issn" => "03002896"
"doi" => "10.1016/j.arbres.2023.06.010"
"estado" => "S300"
"fechaPublicacion" => "2023-09-01"
"aid" => "3344"
"copyright" => "SEPAR"
"documento" => "article"
"crossmark" => 1
"subdocumento" => "fla"
"cita" => "Arch Bronconeumol. 2023;59:575-80"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:1 [
"total" => 0
]
"en" => array:13 [
"idiomaDefecto" => true
"cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
"titulo" => "Identification of Low-risk Patients With Acute Symptomatic Pulmonary Embolism"
"tienePdf" => "en"
"tieneTextoCompleto" => "en"
"tieneResumen" => array:2 [
0 => "en"
1 => "en"
]
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "575"
"paginaFinal" => "580"
]
]
"contieneResumen" => array:1 [
"en" => true
]
"contieneTextoCompleto" => array:1 [
"en" => true
]
"contienePdf" => array:1 [
"en" => true
]
"resumenGrafico" => array:2 [
"original" => 1
"multimedia" => array:5 [
"identificador" => "fig0010"
"tipo" => "MULTIMEDIAFIGURA"
"mostrarFloat" => false
"mostrarDisplay" => true
"figura" => array:1 [
0 => array:4 [
"imagen" => "fx1.jpeg"
"Alto" => 1085
"Ancho" => 749
"Tamanyo" => 85295
]
]
]
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "David Jiménez, Behnood Bikdeli, Carmen Rodríguez, Alfonso Muriel, Aitor Ballaz, Silvia Soler, Sebastian Schellong, Aída Gil-Díaz, Andris Skride, Antoni Riera-Mestre, Manuel Monreal"
"autores" => array:12 [
0 => array:2 [
"nombre" => "David"
"apellidos" => "Jiménez"
]
1 => array:2 [
"nombre" => "Behnood"
"apellidos" => "Bikdeli"
]
2 => array:2 [
"nombre" => "Carmen"
"apellidos" => "Rodríguez"
]
3 => array:2 [
"nombre" => "Alfonso"
"apellidos" => "Muriel"
]
4 => array:2 [
"nombre" => "Aitor"
"apellidos" => "Ballaz"
]
5 => array:2 [
"nombre" => "Silvia"
"apellidos" => "Soler"
]
6 => array:2 [
"nombre" => "Sebastian"
"apellidos" => "Schellong"
]
7 => array:2 [
"nombre" => "Aída"
"apellidos" => "Gil-Díaz"
]
8 => array:2 [
"nombre" => "Andris"
"apellidos" => "Skride"
]
9 => array:2 [
"nombre" => "Antoni"
"apellidos" => "Riera-Mestre"
]
10 => array:2 [
"nombre" => "Manuel"
"apellidos" => "Monreal"
]
11 => array:1 [
"colaborador" => "the RIETE Investigators"
]
]
]
]
"resumen" => array:1 [
0 => array:3 [
"titulo" => "Graphical abstract"
"clase" => "graphical"
"resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0010"></elsevierMultimedia></p></span>"
]
]
]
"idiomaDefecto" => "en"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289623002090?idApp=UINPBA00003Z"
"url" => "/03002896/0000005900000009/v2_202311210635/S0300289623002090/v2_202311210635/en/main.assets"
]
"itemAnterior" => array:18 [
"pii" => "S030028962300176X"
"issn" => "03002896"
"doi" => "10.1016/j.arbres.2023.05.017"
"estado" => "S300"
"fechaPublicacion" => "2023-09-01"
"aid" => "3331"
"copyright" => "SEPAR"
"documento" => "article"
"crossmark" => 1
"subdocumento" => "fla"
"cita" => "Arch Bronconeumol. 2023;59:556-65"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:1 [
"total" => 0
]
"en" => array:13 [
"idiomaDefecto" => true
"cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
"titulo" => "Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease"
"tienePdf" => "en"
"tieneTextoCompleto" => "en"
"tieneResumen" => array:2 [
0 => "en"
1 => "en"
]
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "556"
"paginaFinal" => "565"
]
]
"contieneResumen" => array:1 [
"en" => true
]
"contieneTextoCompleto" => array:1 [
"en" => true
]
"contienePdf" => array:1 [
"en" => true
]
"resumenGrafico" => array:2 [
"original" => 1
"multimedia" => array:5 [
"identificador" => "fig0025"
"tipo" => "MULTIMEDIAFIGURA"
"mostrarFloat" => false
"mostrarDisplay" => true
"figura" => array:1 [
0 => array:4 [
"imagen" => "fx1.jpeg"
"Alto" => 1085
"Ancho" => 1232
"Tamanyo" => 97230
]
]
]
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "Laura Carrasco Hernández, Rosa Mª Girón Moreno, Mari Nieves Balaguer Cartagena, Adrián Peláez, Amparo Sole, Antonio Álvarez Fernández, Almudena Felipe Montiel, Casilda Olveira, Gabriel Olveira, Ainhoa Gómez Bonilla, Beatriz Gómez Crespo, Marta García Clemente, Marta Solís García, Joana Quaresma Vázquez, Enrique Blitz Castro, Jesús Rodríguez González, Andrea Expósito Marrero, Laila Diab-Cáceres, Cristina Ramos Hernández, Ester Zamarrón de Lucas, Concha Prados Sanchez, Marina Blanco Aparicio, Alejandro López Neyra, Verónica Sanz Santiago, Carmen Luna Paredes, Isabel Delgado Pecellín, Óscar Asensio de la Cruz, Esther Quintana Gallego"
"autores" => array:28 [
0 => array:2 [
"nombre" => "Laura"
"apellidos" => "Carrasco Hernández"
]
1 => array:2 [
"nombre" => "Rosa Mª"
"apellidos" => "Girón Moreno"
]
2 => array:2 [
"nombre" => "Mari Nieves"
"apellidos" => "Balaguer Cartagena"
]
3 => array:2 [
"nombre" => "Adrián"
"apellidos" => "Peláez"
]
4 => array:2 [
"nombre" => "Amparo"
"apellidos" => "Sole"
]
5 => array:2 [
"nombre" => "Antonio"
"apellidos" => "Álvarez Fernández"
]
6 => array:2 [
"nombre" => "Almudena"
"apellidos" => "Felipe Montiel"
]
7 => array:2 [
"nombre" => "Casilda"
"apellidos" => "Olveira"
]
8 => array:2 [
"nombre" => "Gabriel"
"apellidos" => "Olveira"
]
9 => array:2 [
"nombre" => "Ainhoa"
"apellidos" => "Gómez Bonilla"
]
10 => array:2 [
"nombre" => "Beatriz"
"apellidos" => "Gómez Crespo"
]
11 => array:2 [
"nombre" => "Marta"
"apellidos" => "García Clemente"
]
12 => array:2 [
"nombre" => "Marta"
"apellidos" => "Solís García"
]
13 => array:2 [
"nombre" => "Joana"
"apellidos" => "Quaresma Vázquez"
]
14 => array:2 [
"nombre" => "Enrique"
"apellidos" => "Blitz Castro"
]
15 => array:2 [
"nombre" => "Jesús"
"apellidos" => "Rodríguez González"
]
16 => array:2 [
"nombre" => "Andrea"
"apellidos" => "Expósito Marrero"
]
17 => array:2 [
"nombre" => "Laila"
"apellidos" => "Diab-Cáceres"
]
18 => array:2 [
"nombre" => "Cristina"
"apellidos" => "Ramos Hernández"
]
19 => array:2 [
"nombre" => "Ester"
"apellidos" => "Zamarrón de Lucas"
]
20 => array:2 [
"nombre" => "Concha"
"apellidos" => "Prados Sanchez"
]
21 => array:2 [
"nombre" => "Marina"
"apellidos" => "Blanco Aparicio"
]
22 => array:2 [
"nombre" => "Alejandro"
"apellidos" => "López Neyra"
]
23 => array:2 [
"nombre" => "Verónica"
"apellidos" => "Sanz Santiago"
]
24 => array:2 [
"nombre" => "Carmen"
"apellidos" => "Luna Paredes"
]
25 => array:2 [
"nombre" => "Isabel"
"apellidos" => "Delgado Pecellín"
]
26 => array:2 [
"nombre" => "Óscar"
"apellidos" => "Asensio de la Cruz"
]
27 => array:2 [
"nombre" => "Esther"
"apellidos" => "Quintana Gallego"
]
]
]
]
"resumen" => array:1 [
0 => array:3 [
"titulo" => "Graphical abstract"
"clase" => "graphical"
"resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall"><elsevierMultimedia ident="fig0025"></elsevierMultimedia></p></span>"
]
]
]
"idiomaDefecto" => "en"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030028962300176X?idApp=UINPBA00003Z"
"url" => "/03002896/0000005900000009/v2_202311210635/S030028962300176X/v2_202311210635/en/main.assets"
]
"asociados" => array:1 [
0 => array:17 [
"pii" => "S0300289623002107"
"issn" => "03002896"
"doi" => "10.1016/j.arbres.2023.06.011"
"estado" => "S300"
"fechaPublicacion" => "2023-09-01"
"aid" => "3345"
"documento" => "simple-article"
"crossmark" => 1
"subdocumento" => "edi"
"cita" => "Arch Bronconeumol. 2023;59:552"
"abierto" => array:3 [
"ES" => true
"ES2" => true
"LATM" => true
]
"gratuito" => true
"lecturas" => array:1 [
"total" => 0
]
"en" => array:9 [
"idiomaDefecto" => true
"cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>"
"titulo" => "Timing of Indwelling Pleural Catheters in Malignant Pleural Effusion—Do Not Delay!"
"tienePdf" => "en"
"tieneTextoCompleto" => "en"
"paginas" => array:1 [
0 => array:1 [
"paginaInicial" => "552"
]
]
"contieneTextoCompleto" => array:1 [
"en" => true
]
"contienePdf" => array:1 [
"en" => true
]
"autores" => array:1 [
0 => array:2 [
"autoresLista" => "Avinash Aujayeb"
"autores" => array:1 [
0 => array:2 [
"nombre" => "Avinash"
"apellidos" => "Aujayeb"
]
]
]
]
]
"idiomaDefecto" => "en"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289623002107?idApp=UINPBA00003Z"
"url" => "/03002896/0000005900000009/v2_202311210635/S0300289623002107/v2_202311210635/en/main.assets"
]
]
"en" => array:20 [
"idiomaDefecto" => true
"cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>"
"titulo" => "Efficacy and Safety of Indwelling Catheter for Malignant Pleural Effusions Related to Timing of Cancer Therapy: A Systematic Review"
"tieneTextoCompleto" => true
"paginas" => array:1 [
0 => array:2 [
"paginaInicial" => "566"
"paginaFinal" => "574"
]
]
"autores" => array:1 [
0 => array:4 [
"autoresLista" => "José M. Porcel, Rosa Cordovilla, Rachid Tazi-Mezalek, Deisy Barrios-Barreto, Javier Pérez-Pallarés, Helder Novais e Bastos, Raquel Martínez-Tomás, Javier Flandes-Aldeyturriaga, Enrique Cases-Viedma, Borja Recalde, Maribel Botana-Rial"
"autores" => array:11 [
0 => array:4 [
"nombre" => "José M."
"apellidos" => "Porcel"
"email" => array:1 [
0 => "jporcelp@yahoo.es"
]
"referencia" => array:2 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">a</span>"
"identificador" => "aff0005"
]
1 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">*</span>"
"identificador" => "cor0005"
]
]
]
1 => array:3 [
"nombre" => "Rosa"
"apellidos" => "Cordovilla"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">b</span>"
"identificador" => "aff0010"
]
]
]
2 => array:3 [
"nombre" => "Rachid"
"apellidos" => "Tazi-Mezalek"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">c</span>"
"identificador" => "aff0015"
]
]
]
3 => array:3 [
"nombre" => "Deisy"
"apellidos" => "Barrios-Barreto"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">d</span>"
"identificador" => "aff0020"
]
]
]
4 => array:3 [
"nombre" => "Javier"
"apellidos" => "Pérez-Pallarés"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">e</span>"
"identificador" => "aff0025"
]
]
]
5 => array:3 [
"nombre" => "Helder"
"apellidos" => "Novais e Bastos"
"referencia" => array:3 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">f</span>"
"identificador" => "aff0030"
]
1 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">g</span>"
"identificador" => "aff0035"
]
2 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">h</span>"
"identificador" => "aff0040"
]
]
]
6 => array:3 [
"nombre" => "Raquel"
"apellidos" => "Martínez-Tomás"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">i</span>"
"identificador" => "aff0045"
]
]
]
7 => array:3 [
"nombre" => "Javier"
"apellidos" => "Flandes-Aldeyturriaga"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">j</span>"
"identificador" => "aff0050"
]
]
]
8 => array:3 [
"nombre" => "Enrique"
"apellidos" => "Cases-Viedma"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">i</span>"
"identificador" => "aff0045"
]
]
]
9 => array:3 [
"nombre" => "Borja"
"apellidos" => "Recalde"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">j</span>"
"identificador" => "aff0050"
]
]
]
10 => array:3 [
"nombre" => "Maribel"
"apellidos" => "Botana-Rial"
"referencia" => array:1 [
0 => array:2 [
"etiqueta" => "<span class="elsevierStyleSup">k</span>"
"identificador" => "aff0055"
]
]
]
]
"afiliaciones" => array:11 [
0 => array:3 [
"entidad" => "Pleural Medicine Unit, Hospital Universitario Arnau de Vilanova, IRBLleida, Lleida, Spain"
"etiqueta" => "a"
"identificador" => "aff0005"
]
1 => array:3 [
"entidad" => "Hospital Universitario de Salamanca, Salamanca, Spain"
"etiqueta" => "b"
"identificador" => "aff0010"
]
2 => array:3 [
"entidad" => "Hospital Universitario Germans Trias i Pujol, Badalona, Spain"
"etiqueta" => "c"
"identificador" => "aff0015"
]
3 => array:3 [
"entidad" => "Hospital Universitario Ramón y Cajal, Madrid, Spain"
"etiqueta" => "d"
"identificador" => "aff0020"
]
4 => array:3 [
"entidad" => "Hospital General Universitario Santa Lucía, Cartagena, Spain"
"etiqueta" => "e"
"identificador" => "aff0025"
]
5 => array:3 [
"entidad" => "Centro Hospitalar Universitário de São João, Porto, Portugal"
"etiqueta" => "f"
"identificador" => "aff0030"
]
6 => array:3 [
"entidad" => "Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Portugal"
"etiqueta" => "g"
"identificador" => "aff0035"
]
7 => array:3 [
"entidad" => "Faculdade de Medicina da Universidade do Porto, Porto, Portugal"
"etiqueta" => "h"
"identificador" => "aff0040"
]
8 => array:3 [
"entidad" => "Hospital Universitario y Politécnico La Fe, Valencia, Spain"
"etiqueta" => "i"
"identificador" => "aff0045"
]
9 => array:3 [
"entidad" => "Fundación Jiménez Díaz, Madrid, Spain"
"etiqueta" => "j"
"identificador" => "aff0050"
]
10 => array:3 [
"entidad" => "Pulmonary Department, Hospital Álvaro Cunqueiro, EOXI Vigo, Pneumovigo I+I Research Group, Health Research Institute Galicia Sur (IIS Galicia Sur), Vigo, Spain"
"etiqueta" => "k"
"identificador" => "aff0055"
]
]
"correspondencia" => array:1 [
0 => array:3 [
"identificador" => "cor0005"
"etiqueta" => "⁎"
"correspondencia" => "Corresponding author."
]
]
]
]
"textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Malignant pleural effusion (MPE) is a marker of advanced cancer, which should be treated symptomatically to preserve quality of life. Although some patients are initially asymptomatic and, therefore, do not require invasive procedures,<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,2</span></a> most eventually develop dyspnea at exertion or rest, and their treatment should aim to alleviate symptoms in a minimally invasive manner.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">1</span></a> Traditionally, pleurodesis with talc has been the treatment of choice for MPE patients. Subsequently, indwelling pleural catheter (IPC) emerged as a valuable option for patients with non-expandable lung or failed pleurodesis,<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,3</span></a> offering long-term symptom control following regular fluid drainage, with the same effectiveness as talc pleurodesis.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">4,5</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Advances in pleural palliation have facilitated the widespread adoption of IPCs as a primary intervention in selected patients with symptomatic recurrent MPE.<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,5</span></a> IPCs’ main advantages over talc slurry pleurodesis <span class="elsevierStyleItalic">via</span> chest tube include a shorter hospital stay and fewer requirements for additional pleural interventions; however, the rate of complications may be higher.<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">2,3</span></a> Furthermore, talc may similarly be instilled through a functioning IPC to achieve pleurodesis.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">6</span></a> According to current guidelines, IPC is a suitable option for both patients with expandable and non-expandable lungs, which can be inserted and managed in the outpatient setting.<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,5,7</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Controversy still exists among oncologists and interventional pulmonologists with respect to the precise timing of the IPC placement, whether it should be placed before or during systemic cancer therapy (SCT) or even wait until SCT completion. Arguments in favor of the first option claim to avoid complications related to pleural effusions, including persistent symptoms, poor quality of life, and development of septations or non-expandable lungs. Arguments in favor of waiting for the oncologic treatment to take effect include: (1) potential risk of IPC infection during administration of some therapies, especially chemotherapy; and (2) potential efficacy of SCT at controlling MPE, thus precluding the need for an IPC. No clear guidelines on this topic exist. Current literature about the timing of IPC insertion in relation to SCT is limited, mainly consisting of small retrospective series or single-arm prospective studies. Moreover, no conclusions can currently be drawn on the usefulness of SCT in MPE control.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">4</span></a> According to current guidelines, definitive pleural interventions should probably not be deferred until SCT has been completed.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">5</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Therefore, our aim was to critically review the existing literature in order to compare the efficacy and safety of IPC insertion for MPE in relation to the timing of SCT, with the IPC being evaluated before, during, or after SCT.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Methods</span><p id="par0025" class="elsevierStylePara elsevierViewall">We performed a systematic review (SR) based on the Cochrane Handbook guidelines of a non-Cochrane review. The PRISMA statement, flow chart, and checklist were being adhered to for the reporting.</p><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Search strategy and selection process</span><p id="par0030" class="elsevierStylePara elsevierViewall">Two librarians developed the search strategy using the PRESS guidelines to cross-check results.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">8</span></a> Medline <span class="elsevierStyleItalic">via</span> PubMed (29/01/2023), Embase (29/01/2023), and Cochrane CENTRAL (29/01/2023) were searched from inception using free and MeSH term synonyms of “malignant pleural effusion” and “indwelling pleural catheter” plus filters for SRs, randomized controlled trials (RCTs), and cohorts (see <a class="elsevierStyleCrossRef" href="#sec0075">supplementary material for the detailed search strategies</a>).</p><p id="par0035" class="elsevierStylePara elsevierViewall">Studies were eligible if they included adult patients with MPE secondary to any metastatic tumor or primary pleural tumors such as mesotheliomas, irrespective of the SCT (chemotherapy, immunotherapy, molecular targeted therapies, or combinations) instituted, and whether or not the lung was trapped. In addition, to be eligible, the intervention for MPE should be ambulatory, and the outcome should have been recorded considering the time of IPC placement in relation to SCT (before, during, or after SCT). Studies with radiotherapy as the only cancer treatment were excluded, as were those in which the results of treated and untreated arms could not be derived separately. Concerning the type of studies, RCTs, quasi-controlled trials, prospective and retrospective cohorts, and case series involving over 20 patients were all eligible. SRs covering the same topic were screened for additional primary studies that had not yet been included. The lists of references of the included studies were likewise scanned for potential further studies that would have been overlooked.</p><p id="par0040" class="elsevierStylePara elsevierViewall">The studies retrieved by the searches were added to an Endnote 21™ (Clarivate Analytics) library and uploaded to the Rayyan® systematic review software (<a href="https://www.rayyan.ai/">https://www.rayyan.ai/</a>), where a pair of reviewers performed the study selection independently. First, duplicates were removed, after which the titles and abstracts were screened to discard unrelated studies. All remaining reports were read in full, and data were collected.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Data collection, risk of bias assessment, and synthesis</span><p id="par0045" class="elsevierStylePara elsevierViewall">For each study, the eligibility criteria were checked upfront; if these were not met, the study was added to the list of excluded studies, with a comment specifying the unmet criteria.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Data collected from the primary studies were transcribed by one of the reviewers into an Excel® template, which were agreed <span class="elsevierStyleItalic">a priori</span> and cross-checked by the other reviewer. The variables to be collected were related to: (1) <span class="elsevierStyleItalic">study</span>: design, year, country, setting (single center or multicenter), follow-up duration; (2) <span class="elsevierStyleItalic">sample</span><span class="elsevierStyleItalic">characteristics</span>: sample size, cancer type, demographic characteristics (age and gender), and performance status (Karnofsky, Eastern Cooperative Oncology Group); (3) <span class="elsevierStyleItalic">lung and pleural effusion characteristics</span>: expandable/non-expandable lung, pleural loculations, and fluid data (malignant or non-malignant cells, pH, cellular predominance); (4) <span class="elsevierStyleItalic">cancer treatment</span>: use of chemotherapy, immunotherapy, molecular targeted therapy or combinations, and lines of therapy; (5) <span class="elsevierStyleItalic">IPC</span>: indication (symptomatic relief, pleurodesis), drainage schedule (on demand, daily), and catheter implantation setting (inpatient or outpatient); (6) <span class="elsevierStyleItalic">outcomes of interest</span>: efficacy (symptom improvement, need for further procedures, total number of procedures or re-interventions required, hospital stay, patient survival, degree of auto-pleurodesis achieved [different definitions], and time to catheter removal); safety (intra-pleural infection or empyema, and extra-pleural infection including cellulitis, exit site and tunnel tract infections; symptomatic loculations, metastasis of the tract, pain, bleeding, or other complications such as obstruction).</p><p id="par0055" class="elsevierStylePara elsevierViewall">For each outcome, the definition, effect measure, crude, and adjusted values, as well as covariates were collected, and results were expressed by timing groups. After plotting all the results in tables, the researchers met in order to discuss visualization of results and aggregability of studies.</p><p id="par0060" class="elsevierStylePara elsevierViewall">To assess the risk of bias within the included studies, the Cochrane Risk of Bias (RoB) tool for RCTs and Risk of Bias In Non-randomized Studies of Interventions (RoBINS-I) for non-randomized studies were employed. Studies were assessed by a single reviewer and then cross-checked by another.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Meta-analysis was only planned if the studies were sufficiently homogeneous. A random-effects (DerSimonian and Laird) method for meta-analysis was used. Specifically, a meta-analysis on the risk of IPC-related infections from studies which separated data by groups (with and without SCT while IPC was <span class="elsevierStyleItalic">in situ</span>) was performed. Heterogeneity was estimated from an inverse-variance fixed-effect model and presented as <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span>. The Stata 12.0 (Stata Statistical Software: Release 12. College Station, TX: StataCorp LLC) metaprop and metan commands were used.</p></span></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Results</span><p id="par0070" class="elsevierStylePara elsevierViewall">The search identified 971 records, 10 of which were eventually included (see <a class="elsevierStyleCrossRef" href="#sec0075">Fig. 1S in the Supplementary material</a>). Seventy studies that were likely to meet the inclusion criteria based on their title or abstract were excluded following detailed reading. A list of the studies that were excluded with sufficient reasons is detailed in the <a class="elsevierStyleCrossRef" href="#sec0075">Supplementary material (Tables 1S and 2S)</a>. Most studies were excluded because they did not provide enough data to analyze the outcomes by timing of SCT. The reference lists of three SRs with potentially eligible studies were cross-checked,<a class="elsevierStyleCrossRefs" href="#bib0165"><span class="elsevierStyleSup">7,9,10</span></a> with no additional studies identified by this or by secondary searches.</p><p id="par0075" class="elsevierStylePara elsevierViewall">In <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>, the 10 included studies (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2907 patients; 3066 IPCs) have been summarized, with their risk of bias being listed.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">11–20</span></a> No RCT was identified, and there were only two studies with a prospective design.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">16,17</span></a> The remaining studies exhibited retrospective designs with variable follow-up times (from a median of 107 days to a minimum of 18 months), and two were multicenter in nature.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12,19</span></a> Except for the study by Wilshire et al.,<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a> the remainder displayed moderate to high risk of bias.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">The most common primary tumors were lung (frequency range: 7.3–100%) and breast cancers (12–100%), followed by mesotheliomas, lymphomas or other hematological cancers, ovarian, gastrointestinal, and solid tumors (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Information about MPE and IPC characteristics was scarce. Loculations were only reported in two studies,<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">11,20</span></a> pleural fluid characteristics in three,<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">15,18,20</span></a> while the percentage of trapped lung ranged from 2% to 42%,<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">11,12,15,18</span></a> with IPC insertion being mainly ambulatory (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>). Regarding SCT, different treatments (chemotherapy, radiotherapy, immunotherapy, molecular targeted therapies) with different timings in relation to IPC insertion (before IPC, while IPC was in place, or after IPC removal) were reported. All studies comprised at least one group of patients receiving SCT, but the most common comparison groups were SCT <span class="elsevierStyleItalic">vs</span> no SCT whilst IPC was <span class="elsevierStyleItalic">in situ</span> (<a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><elsevierMultimedia ident="tbl0020"></elsevierMultimedia><p id="par0085" class="elsevierStylePara elsevierViewall">Efficacy and safety outcomes were evaluated, even though they were not always documented in all studies.</p><p id="par0090" class="elsevierStylePara elsevierViewall">Given there were no comparative studies included, it was not possible to assess the efficacy related to symptom improvement or decreased hospitalization days in IPC carriers undergoing SCT. Of the included studies, only three reported re-intervention procedures,<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12,17,18</span></a> seven patient survival,<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">11,13,15–19</span></a> six indication for catheter removal,<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12,15–18,20</span></a> and eight time to catheter removal<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12–16,18–20</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>).</p><elsevierMultimedia ident="tbl0025"></elsevierMultimedia><p id="par0095" class="elsevierStylePara elsevierViewall">Safety data were collected by assessing the following information: intra- or extra-pleural infections (all the included studies), symptomatic loculations,<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> metastasis of the tract,<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> and other complications<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">13,17,18,20</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>).</p><elsevierMultimedia ident="tbl0030"></elsevierMultimedia><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Impact on survival</span><p id="par0100" class="elsevierStylePara elsevierViewall">Survival was expressed as median survival time, 6-month mortality, and mortality with IPC <span class="elsevierStyleItalic">in situ</span>. All studies demonstrated a more prolonged survival in those patients in whom the IPC was inserted close to SCT or during SCT.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">11,13,15–19</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Akram et al. reported that patients who received chemotherapy before and after IPC insertion exhibited longer median survival in comparison with those who did not receive any oncological treatment (106 <span class="elsevierStyleItalic">vs</span> 41 days; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.004).<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> Consequently, the decision regarding institution of the oncological treatment is an essential factor contributing to survival. According to Hak et al. the 6-month mortality was lower in patients with IPC and concomitant SCT than in those without SCT (35% <span class="elsevierStyleItalic">vs</span> 59%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.007).<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> The results of Morel et al. pointed toward the same direction, with lower mortality rates in patients undergoing SCT upon IPC insertion compared with those who did not receive SCT (57% <span class="elsevierStyleItalic">vs</span> 68%), although there was no mention of whether this difference was statistically significant.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a> The study by Ost et al. demonstrated an improvement in quality-adjusted survival in patients starting chemo- or radiotherapy immediately after IPC insertion.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> Mitchell et al. showed that chemotherapy in IPC carriers increased survival time (238 <span class="elsevierStyleItalic">vs</span> 114 days),<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> defined as the median time from IPC insertion to death. Finally, Whilshire et al. observed that SCT within a month of IPC insertion or during IPC use was associated with a 16% increase in survival (hazard ratio [HR]<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.84; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.015).<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">Conducting a meta-analysis was not considered, given the variability of the outcomes and definition of the interventions.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Indication to remove IPC and duration of IPC insertion</span><p id="par0115" class="elsevierStylePara elsevierViewall">Death and auto-pleurodesis were the most common causes of IPC removal.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12,15–18,20</span></a> The rate of spontaneous pleurodesis was high, ranging between 23% and 50% (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>). Although using concomitant chemotherapy when the IPC was <span class="elsevierStyleItalic">in situ</span> did not impact probability of removal in two studies,<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">15,18</span></a> Wang et al. observed greater rates of spontaneous pleurodesis in patients with lung cancer who were subjected to epidermal growth factor receptor (<span class="elsevierStyleItalic">EGFR</span>) therapy while the IPC was <span class="elsevierStyleItalic">in situ</span> (adjusted OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3.87)<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>).</p><p id="par0120" class="elsevierStylePara elsevierViewall">On the other hand, information on the duration of the IPC <span class="elsevierStyleItalic">in situ</span> was not fully consistent.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12–16,18–20</span></a> Although the variability of the studies does not allow drawing solid conclusions, the results suggested longer catheter duration in patients undergoing SCT, except for the Hak et al. study.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> However, the differences were only statistically significant in the Mekhaiel et al. study<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> and could be related to longer survival with chemotherapy. Concerning the remaining studies, multivariate analyses either did not reveal differences between patients with or without SCT upon IPC placement<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> or the statistical significance of the comparison was not recorded.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">13,16,18,19</span></a></p><p id="par0125" class="elsevierStylePara elsevierViewall">Performing a meta-analysis was not taken into consideration, owing to the difficulty of pooling median times and interquartile ranges, which were the most reported effect measures.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Re-interventions</span><p id="par0130" class="elsevierStylePara elsevierViewall">Three studies presented data about additional pleural procedures being required. Overall, the frequency of pleural re-interventions was low, but the results were mainly descriptive, without any comparison between patients with or without chemotherapy while the IPC was <span class="elsevierStyleItalic">in</span><span class="elsevierStyleItalic">situ</span>.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12,17,18</span></a> Nevertheless, in the study by Gilbert et al.,<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> where all 91 patients included underwent chemotherapy, no additional thoracocentesis was reported, and there was only one placement of a chest tube (1.1%), and 3 thoracoscopic pleurodesis procedures (3.3%) (<a class="elsevierStyleCrossRef" href="#tbl0025">Table 5</a>).</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">IPC-related infections</span><p id="par0135" class="elsevierStylePara elsevierViewall">All the included studies presented data on IPC-related infections, whether intrapleural (empyema) or extrapleural (cellulitis, exit site infection or line tract infection). Nevertheless, the direct effect of SCT and the precise time of infection during treatment were not properly evaluated by all the authors.</p><p id="par0140" class="elsevierStylePara elsevierViewall">The overall infection prevalence was highly variable, which can probably be accounted for by methodological differences among studies. Overall, IPC-related infections ranged from 1.9%<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> to as high as 25.4% in one publication,<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> but in the latter the authors did not specify the infection sites. By infection location, the presence of empyema as a complication of IPC ranged from 1%<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> to 8%,<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> while infections pertaining to the extra-pleural space (cellulitis) exhibited less variation, from 0.7%<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> to 4%.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> The pooled estimated rate of IPC-related infections was 2.85% (95% confidence interval: 2.24–3.45; <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span> 73.39%) (<a class="elsevierStyleCrossRef" href="#sec0075">Fig. 2S</a>).</p><p id="par0145" class="elsevierStylePara elsevierViewall">Two of the 10 included studies did not present data on the possible relationship between infection occurrence and SCT timing.<a class="elsevierStyleCrossRefs" href="#bib0185"><span class="elsevierStyleSup">11,20</span></a> The Akram et al. study reported a significant reduction (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.03) in the infection rate of patients receiving domiciliary care education, but the infection frequency was not analyzed in relation with the chemotherapy timing.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> Wang et al. reported a prevalence of intra-pleural infection of 1.9%, also without information on its possible relationship with SCT timing.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> The association between complications and SCT timing was analyzed globally, clearly demonstrating that SCT with concurrent or sequential radiotherapy following IPC insertion did not at all increase the overall risk of complications. The association between infection and SCT timing in relation to IPC insertion was analyzed in eight of the 10 studies.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12–19</span></a> None of them found a significant increase in infection risk associated with the SCT timing, despite the presence of neutropenia<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">12–19</span></a> (<a class="elsevierStyleCrossRef" href="#tbl0030">Table 6</a>). A meta-analysis showed that the pooled relative risk (RR) of IPC-related infections while on SCT compared to off-therapy was 0.98 (95% CI: 0.93–1.03; <span class="elsevierStyleItalic">I</span><span class="elsevierStyleSup">2</span> 0.0%) (<a class="elsevierStyleCrossRef" href="#sec0075">Fig. 3S</a>).</p><p id="par0150" class="elsevierStylePara elsevierViewall">Other outcomes comprised IPC-related pain and drain blockage, without any effect of SCT timing,<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> in addition to symptomatic loculations, metastasis of the tract, leaks, or tumor seeding which were not analyzed with respect to SCT.<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">18,20</span></a></p></span></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Discussion</span><p id="par0155" class="elsevierStylePara elsevierViewall">IPC placement, as an early measure in MPE management, is an adequate option to relief symptoms, maintain quality of life and reduce hospital stays, while potentially reducing the costs related to the latter.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">21</span></a> However, definitive MPE management is not without complications and the optimal timing of IPC insertion with respect to SCT is still controversial. Some clinicians advocate delaying MPE control, while expecting the response to SCT, whereas others argue that MPE recurrences are the rule, thus resulting in deterioration of the patient's condition and reducing the possibility of further definitive interventions owing to lung entrapment.<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">22</span></a> This systematic review compared the safety and effectiveness of IPCs in relation to the timing of antineoplastic treatment, mainly consisting of chemotherapy (before IPC insertion, while IPC was <span class="elsevierStyleItalic">in situ</span>, and after IPC removal).</p><p id="par0160" class="elsevierStylePara elsevierViewall">Results show that IPC carriers undergoing SCT have improved survival, irrespective of the timing of treatment (pre- and post-IPC insertion, concomitant with IPC, after IPC, within 1 month of insertion, or during IPC drainage), although these results could also be due to the better functional status of patients with IPC who are able to receive SCT. Moreover, the rate of auto-pleurodesis reported with targeted therapy to <span class="elsevierStyleItalic">EGFR</span> mutations was very high,<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> suggesting that highly effective therapies and overall good disease control increase the probability of spontaneous pleurodesis and early removal of the IPC. In turn, chemotherapy was not a predictor of pleurodesis in the studies included in the current review.<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">15,18</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall">Infection is one of the most common complications of IPC, and the prevalence of infections and their relationship with SCT are of paramount importance. Meta-analytical data from this systematic review suggest that SCT timing exerts no effect on the risk of IPC-related complications, including infections, even in immunocompromised patients with treatment-induced neutropenia.</p><p id="par0170" class="elsevierStylePara elsevierViewall">These results are in concordance with the scientific literature. In a longitudinal study involving newly diagnosed MPE due to lung cancer, Chiang et al. demonstrated that early MPE control measures were beneficial at reducing the frequency of further interventions, regardless of the anti-cancer therapies used, including molecular targeted therapy.<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">21</span></a> Other studies have also supported the use of definitive pleural treatments (IPC or pleurodesis) in lung cancer patients with oncogenic mutations, without deferring until the eventual response to targeted therapies become apparent.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">23</span></a> In a retrospective analysis of MPEs from different tumor types, Holling et al. observed that SCT was not independently associated with MPE resolution, defined by radiologic resolution with removal of drain or catheter and cessation of interventions.<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">24</span></a> Based on these results, the authors stated that all patients with MPE should be offered early definitive pleural interventions, regardless of the oncologic treatment plan,<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,25,26</span></a> as an integral part of the early palliative care program.</p><p id="par0175" class="elsevierStylePara elsevierViewall">This systematic review has a few limitations. In general, the quality of the included studies was low to moderate, rendering it necessary to downsize the interpretation of results. First, none of the included studies was a RCT, but rather they were mainly retrospective studies, with only two having a prospective design. Second, most of the studies were conducted at a single center. Therefore, operator-dependent, or other center-related variables may have caused potential selection biases. Other limitations were related to the studies’ statistical power that was insufficient to detect differences, along with inadequate handling of potential confounders. Finally, it was not possible to perform a meta-analysis of some outcomes of clinical interest, such as the time to IPC removal according to the simultaneous administration or nor of SCT.</p><p id="par0180" class="elsevierStylePara elsevierViewall">In view of these results, it is crucial to encourage the scientific community to design a proper and pragmatic RCT that evaluates the true influence of diverse SCT on MPE resolution and, therefore, the role of early IPC placement in this setting. International collaboration with prospective standardized databases or registries would allow for more sounded study designs.</p><p id="par0185" class="elsevierStylePara elsevierViewall">In summary, based on observational evidence, it seems that IPC insertion in patients with MPE should not be delayed pending the beneficial effect of SCT, if any, on pleural fluid clearance. In particular, there should be no concern among clinicians about a potential increased risk of IPC infections in patients undergoing SCT compared to those not receiving SCT, as this has not been demonstrated.</p><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Registration and protocol</span><p id="par0190" class="elsevierStylePara elsevierViewall">The review protocol was registered in PROSPERO, prior to the search strategy, under number CRD42022322026.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Availability of data, code, and other materials</span><p id="par0195" class="elsevierStylePara elsevierViewall">The Endnote® libraries and data extraction forms are available upon reasonable request.</p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Funding</span><p id="par0200" class="elsevierStylePara elsevierViewall">The study was funded by an unrestricted grant from <span class="elsevierStyleGrantSponsor" id="gs1">SH Medical Group</span>.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Conflict of interests</span><p id="par0205" class="elsevierStylePara elsevierViewall">All the authors received consultancy fees from SH medical. In addition, JMP received consultancy fees from Becton Dickinson; RC received honoraria for lectures and participation to advisory boards (Olympus, SH medical, and Spanish Society of Pneumology and Thoracic Surgery).</p><p id="par0210" class="elsevierStylePara elsevierViewall">DBB, JPP, RMT, JFA, ECB, BR, and MBR have no other conflicts of interest.</p></span></span>"
"textoCompletoSecciones" => array:1 [
"secciones" => array:10 [
0 => array:3 [
"identificador" => "xres2019692"
"titulo" => "Abstract"
"secciones" => array:4 [
0 => array:2 [
"identificador" => "abst0005"
"titulo" => "Introduction"
]
1 => array:2 [
"identificador" => "abst0010"
"titulo" => "Methods"
]
2 => array:2 [
"identificador" => "abst0015"
"titulo" => "Results"
]
3 => array:2 [
"identificador" => "abst0020"
"titulo" => "Conclusions"
]
]
]
1 => array:2 [
"identificador" => "xpalclavsec1729205"
"titulo" => "Keywords"
]
2 => array:2 [
"identificador" => "sec0005"
"titulo" => "Introduction"
]
3 => array:3 [
"identificador" => "sec0010"
"titulo" => "Methods"
"secciones" => array:2 [
0 => array:2 [
"identificador" => "sec0015"
"titulo" => "Search strategy and selection process"
]
1 => array:2 [
"identificador" => "sec0020"
"titulo" => "Data collection, risk of bias assessment, and synthesis"
]
]
]
4 => array:3 [
"identificador" => "sec0025"
"titulo" => "Results"
"secciones" => array:4 [
0 => array:2 [
"identificador" => "sec0030"
"titulo" => "Impact on survival"
]
1 => array:2 [
"identificador" => "sec0035"
"titulo" => "Indication to remove IPC and duration of IPC insertion"
]
2 => array:2 [
"identificador" => "sec0040"
"titulo" => "Re-interventions"
]
3 => array:2 [
"identificador" => "sec0045"
"titulo" => "IPC-related infections"
]
]
]
5 => array:3 [
"identificador" => "sec0050"
"titulo" => "Discussion"
"secciones" => array:2 [
0 => array:2 [
"identificador" => "sec0055"
"titulo" => "Registration and protocol"
]
1 => array:2 [
"identificador" => "sec0060"
"titulo" => "Availability of data, code, and other materials"
]
]
]
6 => array:2 [
"identificador" => "sec0065"
"titulo" => "Funding"
]
7 => array:2 [
"identificador" => "sec0070"
"titulo" => "Conflict of interests"
]
8 => array:2 [
"identificador" => "xack705219"
"titulo" => "Acknowledgements"
]
9 => array:1 [
"titulo" => "References"
]
]
]
"pdfFichero" => "main.pdf"
"tienePdf" => true
"fechaRecibido" => "2023-03-02"
"fechaAceptado" => "2023-06-19"
"PalabrasClave" => array:1 [
"en" => array:1 [
0 => array:4 [
"clase" => "keyword"
"titulo" => "Keywords"
"identificador" => "xpalclavsec1729205"
"palabras" => array:5 [
0 => "Malignant pleural effusion"
1 => "Indwelling pleural catheter"
2 => "Chemotherapy"
3 => "Efficacy"
4 => "Safety"
]
]
]
]
"tieneResumen" => true
"resumen" => array:1 [
"en" => array:3 [
"titulo" => "Abstract"
"resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Introduction</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">To compare the efficacy and safety of indwelling pleural catheters (IPC) in relation with the timing of systemic cancer therapy (SCT) (<span class="elsevierStyleItalic">i.e.</span>, before, during, or after SCT) in patients with malignant pleural effusion (MPE).</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Systematic review of randomized controlled trials (RCT), quasi-controlled trials, prospective and retrospective cohorts, and case series of over 20 patients, in which the timing of IPC insertion in relation to that of SCT was provided. Medline (<span class="elsevierStyleItalic">via</span> PubMed), Embase, and Cochrane Library were systematically searched from inception to January 2023. The risk of bias was assessed using the Cochrane Risk of Bias (ROB) tool for RCTs and the ROB in non-randomized studies of interventions (ROBINS-I) for non-randomized designs.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Ten studies (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2907 patients; 3066 IPCs) were included. Using SCT while the IPC was <span class="elsevierStyleItalic">in situ</span> decreased overall mortality, increased survival time, and improved quality-adjusted survival. Timing of SCT had no effect on the risk of IPC-related infections (2.85% overall), even in immunocompromised patients with moderate or severe neutropenia (relative risk 0.98 [95%CI: 0.93–1.03] for patients treated with the combination of IPC and SCT). The inconsistency of the results or the lack of analysis of all outcome measures in relation to the SCT/IPC timing precluded drawing solid conclusions about time to IPC removal or need of re-interventions.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Based on observational evidence, the efficacy and safety of IPC for MPE does not seem to vary depending on the IPC insertion timing (before, during, or after SCT). The data most likely support early IPC insertion.</p></span>"
"secciones" => array:4 [
0 => array:2 [
"identificador" => "abst0005"
"titulo" => "Introduction"
]
1 => array:2 [
"identificador" => "abst0010"
"titulo" => "Methods"
]
2 => array:2 [
"identificador" => "abst0015"
"titulo" => "Results"
]
3 => array:2 [
"identificador" => "abst0020"
"titulo" => "Conclusions"
]
]
]
]
"NotaPie" => array:1 [
0 => array:2 [
"etiqueta" => "☆"
"nota" => "<p class="elsevierStyleNotepara" id="npar0040"><span class="elsevierStyleBold">Registration number.</span> PROSPERO 2022 CRD42022322026.</p>"
]
]
"apendice" => array:1 [
0 => array:1 [
"seccion" => array:1 [
0 => array:4 [
"apendice" => "<p id="par0225" class="elsevierStylePara elsevierViewall">The following are the supplementary data to this article:<elsevierMultimedia ident="upi0005"></elsevierMultimedia></p>"
"etiqueta" => "Appendix A"
"titulo" => "Supplementary data"
"identificador" => "sec0080"
]
]
]
]
"multimedia" => array:7 [
0 => array:8 [
"identificador" => "tbl0005"
"etiqueta" => "Table 1"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at1"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:3 [
"leyenda" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Abbreviation</span>: IQR, interquartile range.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Author, year \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Country \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Design (study time period) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Setting \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Follow-up duration \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Risk of bias<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Akram et al., 2020<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Pakistan \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2011–2019) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Not mentioned \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">High \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Gilbert et al., 2015<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">USA \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2009–2013) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Multicentric (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>8) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Not mentioned \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">High \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hak et al., 2016<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">United Kingdom \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2010–2014) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">6 months \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">High \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mekhaiel et al., 2013<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">USA \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2005–2011) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Not mentioned \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">High \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mitchell et al., 2018<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Canada \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2006–2015) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Minimum 18 months \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">High \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Morel et al., 2011<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">United Kingdom \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Prospective (2006–2010) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Not mentioned \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">High \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Ost et al., 2014<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">USA \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Prospective (2010–2013) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Minimum 1 year \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Moderate \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Porcel et al., 2020<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Spain \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2014–2019) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median (IQR): 107 (29–357) days \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Moderate \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wilshire et al., 2021<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">International \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2008–2016) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Multicentric (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>12) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Not mentioned \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Low \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wang et al., 2023<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Canada \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Retrospective (2009–2020) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hospital (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Minimum 18 months \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">High \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab3351606.png"
]
]
]
"notaPie" => array:1 [
0 => array:3 [
"identificador" => "tblfn0005"
"etiqueta" => "a"
"nota" => "<p class="elsevierStyleNotepara" id="npar0005">From the assessment using the Cochrane tools.</p>"
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Description of the included studies.</p>"
]
]
1 => array:8 [
"identificador" => "tbl0010"
"etiqueta" => "Table 2"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at2"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:3 [
"leyenda" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Abbreviations</span>: ChT, chemotherapy; ECOG, Eastern Cooperative Oncology Group; IPC, indwelling pleural catheter; LENT (L<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>LDH in pleural fluid; E<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>ECOG performance status; NLR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>neutrophil to lymphocyte ratio; T<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>tumor type). In papers without information on the number of IPCs inserted at least the same number of procedures as patients was assumed.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Author, year \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">No. patients (IPC) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " colspan="2" align="center" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Age, yr<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">a</span></a></th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " colspan="2" align="center" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Women<span class="elsevierStyleItalic">N</span> (%)</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " colspan="3" align="center" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cancer type</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Performance status/risk stratification \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Breast \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Lung \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Others \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Akram et al., 2020<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">110 (110) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">49 (15)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">76 (69%)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">53.6% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">7.3% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Lymphoma (10.0%)Gastrointestinal (8.2%)Ovarian (7.3%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Risk stratification (LENT score):- low risk: 40%- moderate risk: 26.4%- high risk: 33.6% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Gilbert et al., 2015<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">91 (91) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">65 (15)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">65 (26%)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Lymphoma (62%)Leukemia (21%)Myeloma (13%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hak et al., 2016<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">104 (104) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT on (=43)64 (15) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT off (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>61)68 (12) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">–</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">26.0% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">32.7% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mesothelioma (11.5%)Others (29.8%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mekhaiel et al., 2013<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">243 (262) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">69 (59–77)<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">b</span></a></td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">123 (51)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">16% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">41% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Lymphoma (7%)Ovarian (7%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mitchell et al., 2018<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">207 (216) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">62 (14)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">205 (99)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">100% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- ECOG 1: 3.7%- ECOG 2: 24.1%- ECOG 3: 40.3%- ECOG 4: 31.9% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Morel et al., 2011<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">78 (82) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT on60 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT off67 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT on12 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT off25 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">27% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">16.7% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mesothelioma (23.1%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Ost et al., 2014<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">266 (266) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">60 (12)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">166 (62.4)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">25.2% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">29.7% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hematologic (12.8%)Other solid tumors (32.3%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- ECOG 1: 40.2%- ECOG 2: 31.6%- ECOG 3: 23.7%- ECOG 4: 0.7% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Porcel et al., 2020<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">258 (279) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">71 (61–81)<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">b</span></a></td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">110 (43)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">12% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">43% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Gastrointestinal (11%)Unknown origin (9%)Hematologic (7%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- ECOG 0–1: 50%- ECOG 2: 25%- ECOG 3–4: 25%Risk stratification (LENT score):- low risk: 7%- moderate risk: 65%- high risk: 28% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wilshire et al., 2021<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">1318 (1408) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">63 (54–72)<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">b</span></a></td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">752 (57)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">20% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">36% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Ovarian (5%)Lymphoma (4%)Mesothelioma (4%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- ECOG 0–2: 76%- ECOG 3–4: 24% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wang et al., 2023<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">232 (248) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">71 (12)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " colspan="2" align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">124 (50)</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">100% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- ECOG 0–2: 71.8%- ECOG 3–4: 28.2% \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab3351604.png"
]
]
]
"notaPie" => array:2 [
0 => array:3 [
"identificador" => "tblfn0010"
"etiqueta" => "a"
"nota" => "<p class="elsevierStyleNotepara" id="npar0010">Mean (standard deviation) unless otherwise noted.</p>"
]
1 => array:3 [
"identificador" => "tblfn0015"
"etiqueta" => "b"
"nota" => "<p class="elsevierStyleNotepara" id="npar0015">Median (interquartile range).</p>"
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Included studies: sample characteristics.</p>"
]
]
2 => array:8 [
"identificador" => "tbl0015"
"etiqueta" => "Table 3"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at3"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:2 [
"leyenda" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Abbreviations</span>: CRP, C-reactive protein; LDH, lactate dehydrogenase.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Loculations \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Fluid characteristics \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Trapped lung \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Drainage schedule \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Insertion setting \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Akram et al., 2020<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Non-loculated: 60.9%Multiloculated: 39.1% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">41.8% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Inpatient: 73.6%Outpatient: 26.4% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Gilbert et al., 2015<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">16% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Inpatient (71%) \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hak et al., 2016<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mostly outpatient \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mitchell et al., 2018<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Positive cytology: 40.3% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">15.7% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Thrice weekly for the first two weeks \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Inpatient and outpatient \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Morel et al., 2011<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Ost et al., 2014<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">2% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">• After IPC insertion: daily drainage• Drainage ≤150<span class="elsevierStyleHsp" style=""></span>mL for three consecutive days: drain every other day• Drainage every other day ≤150<span class="elsevierStyleHsp" style=""></span>mL on three occasions and steady decline: stop drainage \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Inpatient: 30.4Outpatient: 69.5 \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Porcel et al., 2020<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">CRP<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>15<span class="elsevierStyleHsp" style=""></span>mg/L: 53%LDH<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>700<span class="elsevierStyleHsp" style=""></span>U/L: 44% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">34% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Three times weekly initially \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Inpatient and outpatient \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wang et al., 2023<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Loculations needing fibrinolytics: 16.0% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Positive cytology: 72.2% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Home care services three times weekly initially \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Inpatient, outpatient or during thoracoscopy \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab3351608.png"
]
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Characteristics of pleural effusions and indwelling pleural catheters in the included studies, where available.</p>"
]
]
3 => array:8 [
"identificador" => "tbl0020"
"etiqueta" => "Table 4"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at4"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:2 [
"leyenda" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Abbreviations</span>: ALK, anaplastic lymphoma kinase; ChT, chemotherapy; EGFR, epidermal grow factor receptor; HSCT, hematopoietic stem cell transplantation; IPC, indwelling pleural catheter; RdT, radiotherapy; SCT, systemic cancer therapy.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Author, year \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cancer treatment \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Timing of cancer treatment-IPC insertion (%) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Treatment line \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Akram et al., 2020<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Pre- and post-IPC insertion: 46.4%- None: 53.6% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Gilbert et al., 2015<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChTPrevious HSCT: 18% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- At the time of IPC insertion: 43%- Within the past 6 weeks: 19%- >6 weeks ago: 25%- Unknown: 13% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hak et al., 2016<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">SCT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Concomitantly: 40%- None: 60% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mekhaiel et al., 2013<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- ChT within 6 weeks of IPC insertion or while IPC was <span class="elsevierStyleItalic">in situ</span>: 66%- No ChT while IPC <span class="elsevierStyleItalic">in situ</span>: 34% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mitchell et al., 2018<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- ChT while IPC <span class="elsevierStyleItalic">in situ</span>: 48.2%- No ChT while IPC <span class="elsevierStyleItalic">in situ</span>: 51.8% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- First: 17.3%- Second: 29.8%- ≥Third: 52.9% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Morel et al., 2011<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">SCT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- SCT while IPC <span class="elsevierStyleItalic">in situ</span>: 28%- No SCT while IPC <span class="elsevierStyleItalic">in situ</span>: 72% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Average: 2.5 cycles with IPC <span class="elsevierStyleItalic">in situ</span> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Ost et al., 2014<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChTRdT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Prior RdT: 12.4%- Prior ChT: 75.6%- ChT or RdT after the procedure: 70.7% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Porcel et al., 2020<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Concomitantly: 63% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wilshire et al., 2021<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">SCT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Within 1 month of IPC insertion and/or during IPC drainage (63%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wang et al., 2023<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT: 19%EGFR targeted therapy: 15.3%ALK targeted therapy: 3.6%Immunotherapy: 15.7%RdT: 13.3%No medication treatment: 29.8% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">While IPC <span class="elsevierStyleItalic">in situ</span> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Second line \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab3351607.png"
]
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Characteristics of cancer treatments in the included studies.</p>"
]
]
4 => array:8 [
"identificador" => "tbl0025"
"etiqueta" => "Table 5"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at5"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:2 [
"leyenda" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Abbreviations</span>: ChT, chemotherapy; ECOG, Eastern Cooperative Oncology Group; EGFR, epidermal grow factor receptor; HR, hazard ratio; IQR, interquartile range; IPC, indwelling pleural catheter; RdT, radiotherapy; SCT, systemic cancer therapy; SHR, sub-hazard ratio.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Author, year \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Pleural re-interventions \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Patient survival \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Indication for removal \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Time to catheter removal \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Akram et al., 2020<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median survival (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.04):- ChT off: 41 days- ChT pre–post-IPC: 106 days \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Gilbert et al., 2015<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4- 3 thoracoscopic pleurodesis- 1 chest tube \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Death: 58%- Autopleurodesis: 23%- Infection: 4%- Patient request: 7% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Global: 89.9<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>127.1 days- If spontaneous pleurodesis: 63<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>48 daysChT did not affect time to removal \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hak et al., 2016<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">6-Month mortality (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.007):- SCT on: 35%- SCT off: 59% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median (IQR) IPC <span class="elsevierStyleItalic">in situ</span>:- SCT on: 28 (14–58) days- SCT off: 69 (47–143) days \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mekhaiel et al., 2013<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median duration (IQR) (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.01):- ChT on: 90 (38–162) days- ChT off: 42 (20–116) days \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mitchell et al., 2018<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median time from IPC insertion to death:- ChT on: 238 days- ChT off: 114 days \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Death: 50%- Autopleurodesis: 50%IPC removal (ChT on <span class="elsevierStyleItalic">vs</span> off): OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.16 (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.59) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median time to removal (IQR): 53.5 (23–144.5) daysNo difference in the adjusted analysis between ChT and no-ChT groups \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Morel et al., 2011<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mortality with IPC <span class="elsevierStyleItalic">in situ</span>:- SCT on: 57%- SCT off: 68% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Autopleurodesis: 35% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median duration IPC <span class="elsevierStyleItalic">in situ</span> (IQR):- SCT on: 84 (11–487) days- SCT off: 66 (6–711) days \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Ost et al., 2014<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>21 (14%)- 11 thoracocentesis- 7 IPC reinsertions- 3 chest tubes \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median survival: 171 daysChT or RdT after IPC insertion improved survival (HR 0.17, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.001) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Death or lost to follow-up: 44.3%- Autopleurodesis: 47.7%- Complications or other reasons: 7.9% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Porcel et al., 2020<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"><span class="elsevierStyleItalic">N</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>11 (8%)- 7 IPC reinsertion- 4 thoracocentesis \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median (IQR): 92 (28–293) days \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Pleurodesis: 48%Predictor of removal (adjusted)- ECOG 0–2: SHR 2.22- Expandable lung: SHR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.93- IPC-related symptomatic loculations: SHR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.37ChT did not predict removal \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median (IQR): 50 (27–99) days \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wilshire et al., 2021<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median (IQR): 120 (107–142) daysSCT associated with better survival:HR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.84 (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.015) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median (IQR): 55 (26–118) days \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wang et al., 2023<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Pleurodesis: 42.7%Predictors of removal (adjusted):- ECOG ≤2: OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4.82- EGFR therapy: OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3.87 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Median time to pleurodesis (IQR): 68 (38–140) daysEGFR therapy was associated with earlier pleurodesis: HR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.86 \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab3351609.png"
]
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Outcomes: indwelling pleural catheter efficacy.</p>"
]
]
5 => array:8 [
"identificador" => "tbl0030"
"etiqueta" => "Table 6"
"tipo" => "MULTIMEDIATABLA"
"mostrarFloat" => true
"mostrarDisplay" => false
"detalles" => array:1 [
0 => array:3 [
"identificador" => "at6"
"detalle" => "Table "
"rol" => "short"
]
]
"tabla" => array:3 [
"leyenda" => "<p id="spar0080" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Abbreviations</span>: ChT, chemotherapy; CRP, C-reactive protein; IPC, indwelling pleural catheter; OR, odds ratio; RdT, radiotherapy; SCT, systemic cancer therapy; SHR, sub-hazard ratio.</p>"
"tablatextoimagen" => array:1 [
0 => array:2 [
"tabla" => array:1 [
0 => """
<table border="0" frame="\n
\t\t\t\t\tvoid\n
\t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Author, year \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " colspan="3" align="center" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Infection rate</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Infection risk \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Infection if neutropenic \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Symptomatic loculations \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Metastasis of the tract \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col">Other complications \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr><tr title="table-row"><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Overall \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Intra-pleural (empyema) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black">Extra-pleural (skin, cellulitis, tract) \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th><th class="td" title="\n
\t\t\t\t\ttable-head\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n
\t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Akram et al., 2020<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">11</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">25.4% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>28) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">No information on relation between infection and timing of ChT<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">d</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Gilbert et al., 2015<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">7.7% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>7)<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Timing of ChT related to IPC insertion had no effect on IPC infection risk \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Hak et al., 2016<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">13</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">9.6% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">6.7%<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">c</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">2.9% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">SCT on: 9.3%SCT off: 4.9% (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.311) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">SCT <span class="elsevierStyleItalic">vs</span> non-SCT groups- Pain: 4.7% <span class="elsevierStyleItalic">vs</span> 3.3%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.550- Drain blockage: 2.3% <span class="elsevierStyleItalic">vs</span> 0%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.413 \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mekhaiel et al., 2013<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">6.6% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>16) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">3.8% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">2.3% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT on: 5.2%ChT off: 7.9% (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.42) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Neutropenia 2/16 (12.5%) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Mitchell et al., 2018<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">1.9% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT <span class="elsevierStyleItalic">vs</span> no-ChT: RR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.57 (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.48) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Morel et al., 2011<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">9% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">SCT <span class="elsevierStyleItalic">vs</span> no-SCT: 4% <span class="elsevierStyleItalic">vs</span> 10%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.667 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">3 patients had neutropenia while IPC <span class="elsevierStyleItalic">in situ</span>, but none developed infections \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Ost et al., 2014<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">5% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>13) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">1% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">4% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>10) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">ChT or RdT after IPC insertion did not affect any type of complication (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.74) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Clogged IPC: 3%IPC dislodgment: 1% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Porcel et al., 2020<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">8.6% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>29) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">8% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>26) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">3.6% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>12) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Predictors of infection: Pleural fluid CRP<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>15<span class="elsevierStyleHsp" style=""></span>mg/L (OR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>4.42).ChT did not increase the risk of infection \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">19% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">0.3% \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Mild pain with IPC drainage:46%- Mild cough with IPC drainage: 25%- Pain during or after IPC insertion:13%- IPC blockage: 5.4% \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wilshire et al., 2021<a class="elsevierStyleCrossRef" href="#bib0225"><span class="elsevierStyleSup">19</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">7%<a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">a</span></a> (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>89) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">4% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>49) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">3% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>40) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">SCT was not associated with risk of infection: SHR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.82 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Immunocompromised (moderate or severe neutropenia): 16% SHR<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>1.14; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.690 \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">Wang et al., 2023<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">20</span></a> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">1.9% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>5) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="char" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">0.7% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2) \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">No information on the relationship between infections and timing of SCT \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t"> \t\t\t\t\t\t\n
\t\t\t\t</td><td class="td" title="\n
\t\t\t\t\ttable-entry\n
\t\t\t\t " align="left" valign="\n
\t\t\t\t\ttop\n
\t\t\t\t">- Pain necessitating removal: 1.9% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>5)- Leak at catheter site: 1.1% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3)- Catheter plugged: 1.1% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>3)- Catheter dislodged: 0.7% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2)- Tumor seeding: 0.7% (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2) \t\t\t\t\t\t\n
\t\t\t\t</td></tr></tbody></table>
"""
]
"imagenFichero" => array:1 [
0 => "xTab3351605.png"
]
]
]
"notaPie" => array:4 [
0 => array:3 [
"identificador" => "tblfn0020"
"etiqueta" => "a"
"nota" => "<p class="elsevierStyleNotepara" id="npar0020">16% immunocompromised (9% with moderate neutropenia and 7% with severe neutropenia).</p>"
]
1 => array:3 [
"identificador" => "tblfn0025"
"etiqueta" => "b"
"nota" => "<p class="elsevierStyleNotepara" id="npar0025">Death-related (septic shock: <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>2; 28%). Hospital admission required (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>6; 86%).</p>"
]
2 => array:3 [
"identificador" => "tblfn0030"
"etiqueta" => "c"
"nota" => "<p class="elsevierStyleNotepara" id="npar0030">Neutropenic sepsis in 2/43 patients in the chemotherapy on group (4.6%).</p>"
]
3 => array:3 [
"identificador" => "tblfn0035"
"etiqueta" => "d"
"nota" => "<p class="elsevierStyleNotepara" id="npar0035">Less frequent in those with domiciliary IPC care education (18.2%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.03).</p>"
]
]
]
"descripcion" => array:1 [
"en" => "<p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">Outcomes: indwelling pleural catheter safety.</p>"
]
]
6 => array:5 [
"identificador" => "upi0005"
"tipo" => "MULTIMEDIAECOMPONENTE"
"mostrarFloat" => false
"mostrarDisplay" => true
"Ecomponente" => array:2 [
"fichero" => "mmc1.pdf"
"ficheroTamanyo" => 568569
]
]
]
"bibliografia" => array:2 [
"titulo" => "References"
"seccion" => array:1 [
0 => array:2 [
"identificador" => "bibs0015"
"bibliografiaReferencia" => array:26 [
0 => array:3 [
"identificador" => "bib0135"
"etiqueta" => "1"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "D.J. Feller-Kopman"
1 => "C.B. Reddy"
2 => "M.M. DeCamp"
3 => "R.L. Diekemper"
4 => "M.K. Gould"
5 => "T. Henry"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Am J Respir Crit Care Med"
"fecha" => "2018"
"volumen" => "198"
"paginaInicial" => "839"
"paginaFinal" => "849"
]
]
]
]
]
]
1 => array:3 [
"identificador" => "bib0140"
"etiqueta" => "2"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Recommendations of the Spanish Society of Thoracic Surgery for the management of malignant pleural effusion"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "J.L. Recuero Díaz"
1 => "S. Figueroa Almánzar"
2 => "C. Gálvez Muñoz"
3 => "J. Lázaro Sierra"
4 => "M. López Porras"
5 => "D. Márquez Medina"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Cir Esp (Engl Ed)"
"fecha" => "2022"
"volumen" => "100"
"paginaInicial" => "673"
"paginaFinal" => "683"
]
]
]
]
]
]
2 => array:3 [
"identificador" => "bib0145"
"etiqueta" => "3"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "To TPC or not to TPC? tunneled pleural catheters in nonmalignant pleural effusions"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "S.M. Miller"
1 => "B. Prakash"
2 => "C. Bellinger"
3 => "R. Chin"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Clin Pulm Med"
"fecha" => "2012"
"volumen" => "19"
"paginaInicial" => "232"
"paginaFinal" => "236"
]
]
]
]
]
]
3 => array:3 [
"identificador" => "bib0150"
"etiqueta" => "4"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "ERS/EACTS statement on the management of malignant pleural effusions"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "A.C. Bibby"
1 => "P. Dorn"
2 => "I. Psallidas"
3 => "J.M. Porcel"
4 => "J. Janssen"
5 => "M. Froudarakis"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Eur J Cardiothorac Surg"
"fecha" => "2019"
"volumen" => "55"
"paginaInicial" => "116"
"paginaFinal" => "132"
]
]
]
]
]
]
4 => array:3 [
"identificador" => "bib0155"
"etiqueta" => "5"
"referencia" => array:1 [
0 => array:1 [
"referenciaCompleta" => "BTS Guideline for Pleural Disease 2022. British Thoracic Society. Available from: <a target="_blank" href="https://www.brit-thoracic.org.uk/quality-improvement/guidelines/pleural-disease/">https://www.brit-thoracic.org.uk/quality-improvement/guidelines/pleural-disease/</a> [accessed 27.5.23]."
]
]
]
5 => array:3 [
"identificador" => "bib0160"
"etiqueta" => "6"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Outpatient talc administration by indwelling pleural catheter for malignant effusion"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "R. Bhatnagar"
1 => "E.K. Keenan"
2 => "A.J. Morley"
3 => "B.C. Kahan"
4 => "A.E. Stanton"
5 => "M. Haris"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "N Engl J Med"
"fecha" => "2018"
"volumen" => "378"
"paginaInicial" => "1313"
"paginaFinal" => "1322"
]
]
]
]
]
]
6 => array:3 [
"identificador" => "bib0165"
"etiqueta" => "7"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "M.E.M. Van Meter"
1 => "K.Y. McKee"
2 => "R.J. Kohlwes"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "J Gen Intern Med"
"fecha" => "2011"
"volumen" => "26"
"paginaInicial" => "70"
"paginaFinal" => "76"
]
]
]
]
]
]
7 => array:3 [
"identificador" => "bib0170"
"etiqueta" => "8"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "PRESS peer review of electronic search strategies: 2015 guideline statement"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:6 [
0 => "J. McGowan"
1 => "M. Sampson"
2 => "D.M. Salzwedel"
3 => "E. Cogo"
4 => "V. Foerster"
5 => "C. Lefebvre"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "J Clin Epidemiol"
"fecha" => "2016"
"volumen" => "75"
"paginaInicial" => "40"
"paginaFinal" => "46"
]
]
]
]
]
]
8 => array:3 [
"identificador" => "bib0175"
"etiqueta" => "9"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Quality of life after interventions for malignant pleural effusions: a systematic review"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "P. Sivakumar"
1 => "A. Saigal"
2 => "L. Ahmed"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "BMJ Support Palliat Care"
"fecha" => "2020"
"volumen" => "10"
"paginaInicial" => "45"
"paginaFinal" => "54"
]
]
]
]
]
]
9 => array:3 [
"identificador" => "bib0180"
"etiqueta" => "10"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Talc pleurodesis versus indwelling pleural catheter among patients with malignant pleural effusion: a meta-analysis of randomized controlled trials"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "L. Wang"
1 => "H. Deng"
2 => "X. Chen"
3 => "C. Li"
4 => "F. Yi"
5 => "Y. Wei"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:4 [
"tituloSerie" => "World J Surg Oncol"
"fecha" => "2020"
"volumen" => "18"
"paginaInicial" => "184"
]
]
]
]
]
]
10 => array:3 [
"identificador" => "bib0185"
"etiqueta" => "11"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Predicting the survival in patients with malignant pleural effusion undergoing indwelling pleural catheter insertion"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:6 [
0 => "M.J. Akram"
1 => "U. Khalid"
2 => "M.B. Ashraf"
3 => "M.A. Bakar"
4 => "F.M. Butt"
5 => "F. Khan"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Ann Thorac Med"
"fecha" => "2020"
"volumen" => "15"
"paginaInicial" => "223"
"paginaFinal" => "229"
]
]
]
]
]
]
11 => array:3 [
"identificador" => "bib0190"
"etiqueta" => "12"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "The use of indwelling tunneled pleural catheters for recurrent pleural effusions in patients with hematologic malignancies: a multicenter study"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "C.R. Gilbert"
1 => "H.J. Lee"
2 => "J.H. Skalski"
3 => "F. Maldonado"
4 => "M. Wahidi"
5 => "P.J. Choi"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Chest"
"fecha" => "2015"
"volumen" => "148"
"paginaInicial" => "752"
"paginaFinal" => "758"
]
]
]
]
]
]
12 => array:3 [
"identificador" => "bib0195"
"etiqueta" => "13"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Safety of indwelling pleural catheter use in patients undergoing chemotherapy: a five-year retrospective evaluation"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:3 [
0 => "C.C.W. Hak"
1 => "P. Sivakumar"
2 => "L. Ahmed"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:4 [
"tituloSerie" => "BMC Pulm Med"
"fecha" => "2016"
"volumen" => "16"
"paginaInicial" => "41"
]
]
]
]
]
]
13 => array:3 [
"identificador" => "bib0200"
"etiqueta" => "14"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:4 [
0 => "E. Mekhaiel"
1 => "R. Kashyap"
2 => "J.J. Mullon"
3 => "F. Maldonado"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "J Bronchol Interv Pulmonol"
"fecha" => "2013"
"volumen" => "20"
"paginaInicial" => "299"
"paginaFinal" => "303"
]
]
]
]
]
]
14 => array:3 [
"identificador" => "bib0205"
"etiqueta" => "15"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Effect of chemotherapy on removal of indwelling pleural catheters in breast cancer patients with malignant pleural effusions"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "M.A. Mitchell"
1 => "A. Burkett"
2 => "P. Li"
3 => "T. Zhang"
4 => "K. Amjadi"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Respiration"
"fecha" => "2018"
"volumen" => "96"
"paginaInicial" => "552"
"paginaFinal" => "559"
]
]
]
]
]
]
15 => array:3 [
"identificador" => "bib0210"
"etiqueta" => "16"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "A. Morel"
1 => "E. Mishra"
2 => "L. Medley"
3 => "N.M. Rahman"
4 => "J. Wrightson"
5 => "D. Talbot"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Thorax"
"fecha" => "2011"
"volumen" => "66"
"paginaInicial" => "448"
"paginaFinal" => "449"
]
]
]
]
]
]
16 => array:3 [
"identificador" => "bib0215"
"etiqueta" => "17"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Quality-adjusted survival following treatment of malignant pleural effusions with indwelling pleural catheters"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "D.E. Ost"
1 => "C.A. Jimenez"
2 => "X. Lei"
3 => "S.B. Cantor"
4 => "H.B. Grosu"
5 => "D.R. Lazarus"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Chest"
"fecha" => "2014"
"volumen" => "145"
"paginaInicial" => "1347"
"paginaFinal" => "1356"
]
]
]
]
]
]
17 => array:3 [
"identificador" => "bib0220"
"etiqueta" => "18"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Predictors of indwelling pleural catheter removal and infection: a single-center experience with 336 procedures"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:6 [
0 => "J.M. Porcel"
1 => "M. Torres"
2 => "M. Pardina"
3 => "C. Civit"
4 => "A. Salud"
5 => "S. Bielsa"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "J Bronchol Interv Pulmonol"
"fecha" => "2020"
"volumen" => "27"
"paginaInicial" => "86"
"paginaFinal" => "94"
]
]
]
]
]
]
18 => array:3 [
"identificador" => "bib0225"
"etiqueta" => "19"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Association between tunneled pleural catheter use and infection in patients immunosuppressed from antineoplastic therapy. A multicenter study"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "C.L. Wilshire"
1 => "S.-C. Chang"
2 => "C.R. Gilbert"
3 => "J.A. Akulian"
4 => "M.K. AlSarraj"
5 => "R. Asciak"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Ann Am Thorac Soc"
"fecha" => "2021"
"volumen" => "18"
"paginaInicial" => "606"
"paginaFinal" => "612"
]
]
]
]
]
]
19 => array:3 [
"identificador" => "bib0230"
"etiqueta" => "20"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Effect of chemotherapy, immunotherapy, and targeted therapies on removal of indwelling pleural catheters in non-small cell lung cancer patients with malignant pleural effusions"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:6 [
0 => "M. Wang"
1 => "K. Sparrow"
2 => "C. Chan"
3 => "A. Gillson"
4 => "D. Stollery"
5 => "P. Li"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:4 [
"tituloSerie" => "Respir Med"
"fecha" => "2023"
"volumen" => "206"
"paginaInicial" => "107093"
]
]
]
]
]
]
20 => array:3 [
"identificador" => "bib0235"
"etiqueta" => "21"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "K.Y. Chiang"
1 => "J.C. Ho"
2 => "P. Chong"
3 => "T.C. Tam"
4 => "D.C. Lam"
5 => "M.S. Ip"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Respirology"
"fecha" => "2020"
"volumen" => "25"
"paginaInicial" => "1167"
"paginaFinal" => "1173"
]
]
]
]
]
]
21 => array:3 [
"identificador" => "bib0240"
"etiqueta" => "22"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Predictors of lung entrapment in malignant pleural effusion"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "R. Trovisco"
1 => "C. Freitas"
2 => "M. Serino"
3 => "P. Ferreira"
4 => "B. Martins"
5 => "D. Coelho"
]
]
]
]
]
"host" => array:1 [
0 => array:2 [
"doi" => "10.1016/j.pulmoe.2022.08.00"
"Revista" => array:2 [
"tituloSerie" => "Pulmonology"
"fecha" => "2022"
]
]
]
]
]
]
22 => array:3 [
"identificador" => "bib0245"
"etiqueta" => "23"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Risk factors for and time to recurrence of symptomatic malignant pleural effusion in patients with metastatic non-small cell lung cancer with EGFR or ALK mutations"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "A.J. Schwalk"
1 => "D.E. Ost"
2 => "S.N. Saltijeral"
3 => "H. De La Garza"
4 => "R.F. Casal"
5 => "C.A. Jimenez"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Chest"
"fecha" => "2021"
"volumen" => "159"
"paginaInicial" => "1256"
"paginaFinal" => "1264"
]
]
]
]
]
]
23 => array:3 [
"identificador" => "bib0250"
"etiqueta" => "24"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Is systemic anticancer therapy associated with higher rates of malignant pleural effusion control in people with pharmacologically-sensitive tumours? A retrospective analysis of prospectively collected data"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "N. Holling"
1 => "S. Patole"
2 => "A.R.L. Medford"
3 => "N.A. Maskell"
4 => "A.C. Bibby"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Chest"
"fecha" => "2021"
"volumen" => "160"
"paginaInicial" => "1915"
"paginaFinal" => "1924"
]
]
]
]
]
]
24 => array:3 [
"identificador" => "bib0255"
"etiqueta" => "25"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010"
"autores" => array:1 [
0 => array:2 [
"etal" => false
"autores" => array:5 [
0 => "M.E. Roberts"
1 => "E. Neville"
2 => "R.G. Berrisford"
3 => "G. Antunes"
4 => "N.J. Ali"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:6 [
"tituloSerie" => "Thorax"
"fecha" => "2010"
"volumen" => "65"
"numero" => "Suppl. 2"
"paginaInicial" => "ii32"
"paginaFinal" => "ii40"
]
]
]
]
]
]
25 => array:3 [
"identificador" => "bib0260"
"etiqueta" => "26"
"referencia" => array:1 [
0 => array:2 [
"contribucion" => array:1 [
0 => array:2 [
"titulo" => "Diagnosis and treatment of pleural effusion. Recommendations of the Spanish Society of Pulmonology and Thoracic Surgery. Update 2022"
"autores" => array:1 [
0 => array:2 [
"etal" => true
"autores" => array:6 [
0 => "M. Botana Rial"
1 => "J. Pérez Pallarés"
2 => "E. Cases Viedma"
3 => "F.J. López González"
4 => "J.M. Porcel"
5 => "M. Rodríguez"
]
]
]
]
]
"host" => array:1 [
0 => array:1 [
"Revista" => array:5 [
"tituloSerie" => "Arch Bronconeumol"
"fecha" => "2023"
"volumen" => "59"
"paginaInicial" => "27"
"paginaFinal" => "35"
]
]
]
]
]
]
]
]
]
]
"agradecimientos" => array:1 [
0 => array:4 [
"identificador" => "xack705219"
"titulo" => "Acknowledgements"
"texto" => "<p id="par0215" class="elsevierStylePara elsevierViewall">We acknowledge the help of both María Luisa Maquedano and María García-Puente (Alter Biblio) who performed the search strategies, and of both María Jesús García de Yébenes and Loreto Carmona (Inmusc), who performed the study selection, data collection, risk of bias assessment, and data synthesis.</p>"
"vista" => "all"
]
]
]
"idiomaDefecto" => "en"
"url" => "/03002896/0000005900000009/v2_202311210635/S0300289623001886/v2_202311210635/en/main.assets"
"Apartado" => array:4 [
"identificador" => "93563"
"tipo" => "SECCION"
"es" => array:2 [
"titulo" => "Original Articles"
"idiomaDefecto" => true
]
"idiomaDefecto" => "es"
]
"PDF" => "https://static.elsevier.es/multimedia/03002896/0000005900000009/v2_202311210635/S0300289623001886/v2_202311210635/en/main.pdf?idApp=UINPBA00003Z&text.app=https://www.archbronconeumol.org/"
"EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289623001886?idApp=UINPBA00003Z"
]